Genetic factors that make the bacteria behind cholera so dangerous uncovered

Study reveals key genetic factors in Vibrio cholerae O1 that drive cholera transmission and severity, highlighting targets for novel therapeutic strategies.

Eli Lilly boosts 2024 revenue guidance by $3 billion on Mounjaro, Zepbound sales

Eli Lilly raised its full-year revenue guidance by $3 billion, driven by massive sales of its GLP-1-based diabetes and obesity drugs Mounjaro and Zepbound. The

August 8, 2024

As adult survivors of congenital heart defects grow in numbers, so does need for care and research

Until Jennifer Cortes joined a patient advocacy group of adults who have congenital heart defects, she’d never met anyone outside her family who was living

November 13, 2024

Missouri Considers $10 Million from Opioid Settlements for Psilocybin Research | Psychedelic Invest

Missouri’s legislative body, the House of Representatives, has recently endorsed a budget legislation earmarking $10 million of the state’s opioid settlement proceeds for research grants.

April 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.